- Investing Ideas
- U.S. Pharmaceuticals & Biotech Insider-Bought Value Plays
U.S. Pharmaceuticals & Biotech Insider-Bought Value Plays
Results
7
7 companies
Verrica Pharmaceuticals
Market Cap: US$108.6m
A dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States.
VRCA
US$6.32
7D
12.5%
1Y
35.8%
ImmuCell
Market Cap: US$72.2m
An animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.
ICCC
US$7.98
7D
12.2%
1Y
48.3%
Caris Life Sciences
Market Cap: US$6.0b
An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
CAI
US$21.15
7D
10.6%
1Y
n/a
Champions Oncology
Market Cap: US$83.8m
A technology-enabled research company, provides technology solutions for drug discovery and development in the United States.
CSBR
US$6.04
7D
5.1%
1Y
-23.8%
Elite Pharmaceuticals
Market Cap: US$410.5m
A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.
ELTP
US$0.38
7D
-0.3%
1Y
-4.7%
IM Cannabis
Market Cap: US$2.4m
Engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.
IMCC
US$0.38
7D
1.0%
1Y
-74.3%
Cumberland Pharmaceuticals
Market Cap: US$48.3m
A specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products.
CPIX
US$3.23
7D
3.5%
1Y
-28.1%